Clinical Hematology International

Publishing Information

ISSN

The online ISSN of Clinical Hematology International is 2590-0048.

Publication Schedule

Clinical Hematology International is a quarterly journal which publishes 4 issues per year in March, June, September & December.

Indexation

Clinical Hematology International is a new journal which is expected to publish its first issue in March 2019. As a result, the journal is currently not indexed in any databases yet.

Open Access & Publication Fees

Clinical Hematology International is an open access journal, meaning that all articles are immediately and permanently free to read, download, copy & distribute under the terms of the applicable end-user license (refer to the Copyright & End-User License section on this page for further details). Publication in Clinical Hematology International is free of charge for Authors. All open access publication fees are subsidized by the International Academy for Clinical Hematology (IACH). Note that this is a promotional offer which applies to all papers submitted before 31 December 2019.

Authors who publish in Clinical Hematology International are requested to sign a Journal Publishing Agreement upon acceptance of their article. As part of this agreement, Authors transfer exclusive rights, including full copyright, to the journal owner (IACH), while retaining certain rights themselves (such as, for example, patent, trademark and other intellectual property rights, including research data). For more details, please refer to the Post-Acceptance Rights section in the journal's Author Guidelines. Permitted third-party reuse of the open access articles is subsequently defined by the applicable Creative Commons (CC) end-user license. All articles in Clinical Hematology International are published under the CC BY-NC 4.0 license, meaning that end users can freely share an article (i.e. copy and redistribute the material in any medium or format) and adapt it (i.e. remix, transform and build upon the material) on the condition that proper attribution is given (i.e. appropriate credit, a link to the applicable license and an indication if any changes were made; all in such a way that does not suggest that the licensor endorses the user or the use) and the material is only used for non-commercial purposes. For more information, please refer to the Open Access and User Licenses section in the Atlantis Press Open Access & Article Sharing policy.

Peer Review

Peer review for Clinical Hematology International is under the responsibility of the International Academy for Clinical Hematology (IACH). The journal applies a single-blind peer review process. This means that the names of Reviewers are hidden from the Authors. Each article is typically reviewed by two independent subject experts, with a final decision on acceptance made by the Editor-in-Chief. For more information about the peer review process for this journal, please refer to the Peer Review section in the journal's Author Guidelines.

Code of Ethics & Malpractice Statement

Clinical Hematology International, its owner the International Academy for Clinical Hematology, and its publisher Atlantis Press, all adhere to the ethical standards as outlined in the policies of the Committee on Publication Ethics (COPE). As such, the journal follows the COPE Core Practices and the Principles of Transparency and Best Practice in Scholarly Publishing. All ethical and misconduct cases for this journal are handled according to these guidelines. In addition, the journal follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals issued by the International Committee of Medical Journal Editors (ICMJE) and it is expected of Authors, Editors and Reviewers that they follow the best-practice guidelines on ethical behaviour contained in those recommendations. For more information, please refer to the Atlantis Press Publishing Ethics & Misconduct policy.

DOIs

Each article that is accepted for publication in Clinical Hematology International is assigned a Digital Object Identifier (DOI). DOIs are standardized digital identities which can be used to cite and link to electronic content. A DOI is guaranteed to never change, so can be used as a persistent identifier to permanently link to an electronic article no matter where it is stored. More information on how to cite and use DOIs can be found here.

Permanent Archiving

Clinical Hematology International and its publisher Atlantis Press are committed to the permanent availability and preservation of scholarly research and to ensure accessibility to this research by converting and upgrading digital file formats to comply with new technology standards. Besides maintaining its own digital archive, Atlantis Press therefore collaborates with the National Library of the Netherlands which permanently archives all Atlantis Press content in their “e-Depot”. All issues of Clinical Hematology International are uploaded to this e-Depot after publication to guarantee permanent archiving of the articles. Note that the e-Depot is available through on-site access at the National Library of the Netherlands and if Atlantis Press would be unable to provide access to content on its own platform (temporarily, in an emergency or permanently) access to the e-Depot can be provided to the global public on request.